- call +1-201-465-4211
- email sales@mrinsights.biz
Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites. However, due to increasing consumption of milk and beef products, the need for bovine respiratory disease treatment has increased across the globe.
Scope of the Report:
This report studies the Bovine Respiratory Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bovine Respiratory Disease Treatment market by product type and applications/end industries.
One of the major factors responsible for the market's growth is the increasing interests of several vendors on the development of novel drugs to gain a competitive advantage over their competitors. For instance, Bayer HealthCare launched Zelnate in the US, which is a bacterial-produced plasmid DNA including a liposome carrier that helps to stimulate the innate immune system in cattle. Furthermore, under traditional antibiotics segment also, vendors are launching various drugs such as draxxin for the cattle respiratory disease treatment. The growing focus on the development of combination drugs will drive the growth prospects for the global BRD treatment market for the next few years. Some of the major factors responsible for the growing number of development of combination drugs is the need to offer improved efficacy and ensure better treatment outcomes.
North America accounts for a major share in the global market, of which around 90% is held by the U.S. alone. The bovine respiratory disease treatment market in the U.S. is propelled by the rising domestic production, consumption, and export of bovine meat.
The global Bovine Respiratory Disease Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bovine Respiratory Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bayer HealthCare
Boehringer Ingelheim
Elanco
Merck
Zoetis
Ceva
Inovio Pharmaceuticals
Norbrook Laboratories
Plumbline Life Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Vaccines
Antibiotics
Immunomodulators
Others
Market Segment by Applications, can be divided into
Veterinary Clinics
Veterinary Hospitals
Veterinary Research Institutes
Private Veterinary Pharmacies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Bovine Respiratory Disease Treatment Market Overview
1.1 Product Overview and Scope of Bovine Respiratory Disease Treatment
1.2 Classification of Bovine Respiratory Disease Treatment by Types
1.2.1 Global Bovine Respiratory Disease Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Bovine Respiratory Disease Treatment Revenue Market Share by Types in 2017
1.2.3 Vaccines
1.2.4 Antibiotics
1.2.5 Immunomodulators
1.2.6 Others
1.3 Global Bovine Respiratory Disease Treatment Market by Application
1.3.1 Global Bovine Respiratory Disease Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Veterinary Clinics
1.3.3 Veterinary Hospitals
1.3.4 Veterinary Research Institutes
1.3.5 Private Veterinary Pharmacies
1.4 Global Bovine Respiratory Disease Treatment Market by Regions
1.4.1 Global Bovine Respiratory Disease Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bovine Respiratory Disease Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Bovine Respiratory Disease Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Bayer HealthCare
2.1.1 Business Overview
2.1.2 Bovine Respiratory Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer HealthCare Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boehringer Ingelheim
2.2.1 Business Overview
2.2.2 Bovine Respiratory Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boehringer Ingelheim Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Elanco
2.3.1 Business Overview
2.3.2 Bovine Respiratory Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Elanco Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Bovine Respiratory Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Zoetis
2.5.1 Business Overview
2.5.2 Bovine Respiratory Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Zoetis Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ceva
2.6.1 Business Overview
2.6.2 Bovine Respiratory Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ceva Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Inovio Pharmaceuticals
2.7.1 Business Overview
2.7.2 Bovine Respiratory Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Inovio Pharmaceuticals Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Norbrook Laboratories
2.8.1 Business Overview
2.8.2 Bovine Respiratory Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Norbrook Laboratories Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Plumbline Life Sciences
2.9.1 Business Overview
2.9.2 Bovine Respiratory Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Plumbline Life Sciences Bovine Respiratory Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bovine Respiratory Disease Treatment Market Competition, by Players
3.1 Global Bovine Respiratory Disease Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Bovine Respiratory Disease Treatment Players Market Share
3.2.2 Top 10 Bovine Respiratory Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Bovine Respiratory Disease Treatment Market Size by Regions
4.1 Global Bovine Respiratory Disease Treatment Revenue and Market Share by Regions
4.2 North America Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
5 North America Bovine Respiratory Disease Treatment Revenue by Countries
5.1 North America Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)
5.2 USA Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
6 Europe Bovine Respiratory Disease Treatment Revenue by Countries
6.1 Europe Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)
6.2 Germany Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
6.4 France Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Bovine Respiratory Disease Treatment Revenue by Countries
7.1 Asia-Pacific Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)
7.2 China Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
7.5 India Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
8 South America Bovine Respiratory Disease Treatment Revenue by Countries
8.1 South America Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)
8.2 Brazil Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Bovine Respiratory Disease Treatment by Countries
9.1 Middle East and Africa Bovine Respiratory Disease Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Bovine Respiratory Disease Treatment Revenue and Growth Rate (2013-2018)
10 Global Bovine Respiratory Disease Treatment Market Segment by Type
10.1 Global Bovine Respiratory Disease Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Bovine Respiratory Disease Treatment Market Forecast by Type (2018-2023)
10.3 Vaccines Revenue Growth Rate (2013-2023)
10.4 Antibiotics Revenue Growth Rate (2013-2023)
10.5 Immunomodulators Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)
11 Global Bovine Respiratory Disease Treatment Market Segment by Application
11.1 Global Bovine Respiratory Disease Treatment Revenue Market Share by Application (2013-2018)
11.2 Bovine Respiratory Disease Treatment Market Forecast by Application (2018-2023)
11.3 Veterinary Clinics Revenue Growth (2013-2018)
11.4 Veterinary Hospitals Revenue Growth (2013-2018)
11.5 Veterinary Research Institutes Revenue Growth (2013-2018)
11.6 Private Veterinary Pharmacies Revenue Growth (2013-2018)
12 Global Bovine Respiratory Disease Treatment Market Size Forecast (2018-2023)
12.1 Global Bovine Respiratory Disease Treatment Market Size Forecast (2018-2023)
12.2 Global Bovine Respiratory Disease Treatment Market Forecast by Regions (2018-2023)
12.3 North America Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)
12.6 South America Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Bovine Respiratory Disease Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Bovine Respiratory Disease Treatment Picture
Table Product Specifications of Bovine Respiratory Disease Treatment
Table Global Bovine Respiratory Disease Treatment a
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
